Remote Evaluation of the Naída CI M90 (Marvel) Sound Processor

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

20 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-08-13

Study Completion Date

2023-08-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Within-subject comparison. Remotely Evaluating latest Advanced Bionics Marvel Sound Processor for cochlear implants, from two adult groups.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Investigation of the Naída CI M90 Sound Processor in Various Acoustic Scenarios

NCT04815343

Cochlear Hearing Loss

COMPLETED NA

Investigation of the Automatic Technology on the Naída M Hearing Devices

NCT04610216

Cochlear Hearing Loss

COMPLETED

Cochlear Implant Speech and Non-speech Sound Recognition

NCT03661970

Deafness Sound Perception Quality of Sound

TERMINATED

Clinical Evaluation of a Cochlear Implant Sound Processor

NCT04237207

Hearing Loss Ear Diseases Hearing Disorders +1 more

COMPLETED NA

Cerebral Activation and Bilateral Stimulation by Cochlear Implantation in Bilateral Deaf Adults

NCT02904187

Deafness

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Within-subject comparison, standard of care CE marked Advanced Bionics device. Remote Evaluation of new CI Naida M sound processor through speech understanding in quiet and noise using standard clinical tests, subjective feedback on sound quality for a set of listening situations reflecting everyday use and a ease of use questionnaire. Two adult groups, one CI users and the other bimodal users. All tests completed remotely.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cochlear Hearing Loss Hearing Loss

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* CI users with a CI, HiRes90K (Advantage) or HiRes Ultra cochlear implant system
* Unilaterally implanted recipients using only a Naída Q sound processor
* Bimodal users: additionally using hearing aid on their contralateral ear

* Minimum of 18 years of age
* Minimum of five years' experience with their Naída Q sound processor
* Minimum of six months experience with their contralateral hearing aid (if applicable)
* Ability to give feedback on sound quality
* Speech intelligibility with the BKB sentence test in noise at a +10 dB SNR \> 10% as obtained during previous visits in the clinical routine or BKB \>50% in quiet conditions if noise has previously not been tested
* Fluent in English language

Exclusion Criteria

* Difficulties additional to hearing impairment that would interfere with the study procedures
* Concurrent participation in any other clinical hearing study
* Not due to have their sound processor upgraded in line with normal clinical procedures

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes